Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 3/20 | 0.41 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.41 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.41 |
| ▸ | FAAH | O00519 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.41 |
| ▸ | HTR2C | P28335 | 1/20 | 0.41 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.41 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.41 |
| ▸ | HTR2B | P41595 | 1/20 | 0.41 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2725289 | 1.00 | GABRA1 (0.41) | GABRA1GABRG2GABRB3LMNAGABRB2 | |
| SCHEMBL11863751 | 0.86 | HTR1A (0.40) | GABRA1GABRG2GABRB3LMNAGABRB2 | |
| SCHEMBL28447225 | 0.83 | ROCK2 (0.35) | GABRA1GABRG2GABRB3LMNAGABRB2 | |
| SCHEMBL16115092 | 0.81 | CHRNB2 (0.39) | GABRA1GABRG2GABRB3CA1CA2 | |
| SCHEMBL16951488 | 0.80 | GABRA1 (0.39) | GABRA1GABRG2GABRB3LMNAGABRB2 | |
| SCHEMBL6684632 | 0.80 | GABRA1 (0.39) | GABRA1GABRG2GABRB3LMNAGABRB2 | |
| SCHEMBL4549141 | 0.78 | DRD2 (0.45) | SLC6A2HTR2CSLC6A4 | |
| SCHEMBL16956096 | 0.78 | GABRA1 (0.45) | GABRA1GABRG2GABRB3LMNAGABRB2 | |
| SCHEMBL5600840 | 0.78 | PTGS2 (0.41) | GABRA1GABRG2GABRB3LMNAGABRB2 | |
| SCHEMBL16956094 | 0.76 | GABRA1 (0.39) | GABRA1GABRG2GABRB3LMNAGABRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9718744-B2 | Hydroalkylating process comprising an activation of the hydroalkylation catalyst and method of making phenol and cyclohexanone | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2017-08-01 | — | — | US | claimed |
| US-20160229767-A1 | Hydroalkylating Process Comprising an Activation of the Hydroalkylation Catalyst and Method of Making Phenol and Cyclohexanone | EXXONMOBIL CHEMICAL PATENTS INC. | 2016-08-11 | — | — | US | claimed |
| CN-105636692-A | Hydroalkylating process comprising an activation of the hydroalkylation catalyst and method of making phenol and cyclohexanone. | EXXONMOBIL CHEMICAL PATENTS INC | 2016-06-01 | — | — | CN | claimed |
| US-9144792-B2 | Hydroalkylating process | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2015-09-29 | — | — | US | claimed |
| US-20150112098-A1 | Hydroalkylating Process | EXXONMOBIL CHEMICAL PATENTS INC. | 2015-04-23 | — | — | US | claimed |
| WO-2015057374-A1 | HYDROALKYLATING PROCESS COMPRISING AN ACTIVATION OF THE HYDROALKYLATION CATALYST AND ΜΕΤΗOD OF MAKING PHENOL AND CYCLOHEXANONE. | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2015-04-23 | — | — | WO | claimed |
| US-9718744-B2 | Hydroalkylating process comprising an activation of the hydroalkylation catalyst and method of making phenol and cyclohexanone | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2017-08-01 | — | — | US | disclosed |
| US-20160229767-A1 | Hydroalkylating Process Comprising an Activation of the Hydroalkylation Catalyst and Method of Making Phenol and Cyclohexanone | EXXONMOBIL CHEMICAL PATENTS INC. | 2016-08-11 | — | — | US | disclosed |
| CN-105636692-A | Hydroalkylating process comprising an activation of the hydroalkylation catalyst and method of making phenol and cyclohexanone. | EXXONMOBIL CHEMICAL PATENTS INC | 2016-06-01 | — | — | CN | disclosed |
| US-9169170-B2 | Hydroalkylating process | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2015-10-27 | — | — | US | disclosed |
| US-9144792-B2 | Hydroalkylating process | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2015-09-29 | — | — | US | disclosed |
| WO-2015057374-A1 | HYDROALKYLATING PROCESS COMPRISING AN ACTIVATION OF THE HYDROALKYLATION CATALYST AND ΜΕΤΗOD OF MAKING PHENOL AND CYCLOHEXANONE. | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2015-04-23 | — | — | WO | disclosed |
| US-20150112098-A1 | Hydroalkylating Process | EXXONMOBIL CHEMICAL PATENTS INC. | 2015-04-23 | — | — | US | disclosed |
| US-20150094494-A1 | Hydroalkylating Process | EXXONMOBIL CHEMICAL PATENTS INC. | 2015-04-02 | — | — | US | disclosed |
| EP-2632929-A1 | N-HETEROCYCLIC CARBENE COMPLEXES, THEIR PREPARATION AND USE | BASF SE (DE) | 2013-09-04 | — | — | EP | disclosed |
| WO-2012056419-A1 | N-HETEROCYCLIC CARBENE COMPLEXES, THEIR PREPARATION AND USE | BASF SE (DE) | 2012-05-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150112098-A1 | Hydroalkylating Process | AHR, HACL2, HPD | GABRA1 3140/4885GABRG2 1729/4885GABRB3 1863/4885 |
| US-20160229767-A1 | Hydroalkylating Process Comprising an Activation of the Hydroalkylation Catalyst and Method of Making Phenol and Cyclohexanone | HACL2, HPD, KHK | GABRA1 4509/4885GABRG2 4432/4885GABRB3 4508/4885 |
| US-20150094494-A1 | Hydroalkylating Process | HPD, BCKDK, ALKBH3 | GABRA1 2128/4885GABRG2 1612/4885GABRB3 1594/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.